Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT2 | O60551 | 1/20 | 0.45 |
| ▸ | NMT1 | P30419 | 1/20 | 0.45 |
| ▸ | FURIN | P09958 | 1/20 | 0.42 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28382528 | 1.00 | NMT2 (0.45) | NMT2NMT1FURINGSRDPP8 | |
| SCHEMBL28382531 | 1.00 | NMT2 (0.45) | NMT2NMT1FURINGSRDPP8 | |
| SCHEMBL827833 | 1.00 | NMT2 (0.45) | NMT2NMT1FURINGSRDPP8 | |
| SCHEMBL28453999 | 0.96 | GSR (0.44) | NMT2NMT1GSRDPP8DPP9 | |
| SCHEMBL28453993 | 0.96 | GSR (0.44) | NMT2NMT1GSRDPP8DPP9 | |
| SCHEMBL31593274 | 0.96 | FURIN (0.47) | NMT2NMT1FURIN | |
| SCHEMBL31027958 | 0.94 | NPY1R (0.46) | NMT2NMT1FURINCPB2 | |
| SCHEMBL29364543 | 0.94 | NMT1 (0.47) | NMT2NMT1CPB2TLR2 | |
| SCHEMBL27164802 | 0.94 | CPB2 (0.45) | FURINGSRDPP8DPP9DPP7 | |
| SCHEMBL27165073 | 0.94 | CPB2 (0.45) | FURINGSRDPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024237528-A1 | TARGETED NANOCARRIER FOR WOUND HEALING, AND METHOD FOR MANUFACTURING SAME | 대봉엘에스 주식회사 | 2024-11-21 | — | — | WO | claimed |
| CN-106083996-A | Galla Turcica (Galla Helepensis) acyl peptide derivant and the aging resistance Dermatologic preparation composition containing this derivant | 生物FD&C株式会社 | 2016-11-09 | — | — | CN | claimed |
| US-20140206842-A1 | Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceutical | MAJEED MUHAMMED (US) | 2014-07-24 | — | — | US | claimed |
| US-8383594-B2 | Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals | SAMI LABS LIMITED (IN) | 2013-02-26 | — | — | US | claimed |
| US-20100034758-A1 | Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals | SAMI LABS LIMITED (IN) | 2010-02-11 | — | — | US | claimed |
| US-7521477-B2 | Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2009-04-21 | — | — | US | claimed |
| US-20070093425-A1 | Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2007-04-26 | — | — | US | claimed |
| EP-4103144-B1 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4110277-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-3045161-B1 | Use of active mixtures of 1,2-hexanediol and 1,2-octanediol in cosmetic, pharmaceutical or dermatological emulsions | SYMRISE AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4706780-A2 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2026-03-11 | — | — | EP | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | SYMRISE AG (DE) | 2026-02-05 | — | — | US | disclosed |
| US-7521477-B2 | Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2009-04-21 | — | — | US | disclosed |
| US-20090028897-A1 | COSMETIC USE OF AN ACTIVE AGENT CAPABLE OF STIMULATING TENSIN 1 EXPRESSION | CHANEL PARFUMS BEAUTE (FR) | 2009-01-29 | — | — | US | disclosed |
| WO-2008145692-A2 | COSMETIC COMPOSITION COMPRISING AN ACTIVE AGENT CAPABLE OF STIMULATING TENSIN 1 EXPRESSION | CHANEL PARFUMS BEAUTE (FR) | 2008-12-04 | — | — | WO | disclosed |
| EP-1618125-A4 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO LTD (KR) | 2008-03-26 | — | — | EP | disclosed |
| US-20070093425-A1 | Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same | PEPTRON CO., LTD. (KR) | 2007-04-26 | — | — | US | disclosed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | disclosed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | NMT2 2543/4885NMT1 3106/4885FURIN 4581/4885 |
| US-20070093425-A1 | Vitamin c derivatives with peptide, preparation method thereof and composition comprising the same | PROC, CTRC, GC | NMT2 2377/4885NMT1 2446/4885FURIN 119/4885 |
| US-20100034758-A1 | Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals | CUTA, MMP1, MMP13 | NMT2 3527/4885NMT1 3334/4885FURIN 635/4885 |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | TYR, ERG28, CUTA | NMT2 3771/4885NMT1 3793/4885FURIN 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.